Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility of HBV-MPL Vaccines vs Engerix-B in Adolescents
NCT00697775Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 1998
- Primary completion
- May 1999
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of hepatitis b vaccine recombinant in hepatitis B (HBV), sponsored by GSK. Started Mar 1998; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00697775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00697775.